1. Short title This Act may be cited as the Genomics Expenditures and National Security Enhancement Act of 2023 or the GENE Act . 2. Requirements for reviews of covered transactions involving genetic information (a) Mandatory declarations Section 721(b)(1)(C)(v)(IV) of the Defense Production Act of 1950 ( 50 U.S.C. 4565(b)(1)(C)(v)(IV) ) is amended— (1) by redesignating items (cc) through (gg) as items (dd) through (hh), respectively; and (2) by inserting after item (bb) the following: (cc) Covered transactions involving genetic information The parties to a covered transaction shall submit a declaration described in subclause (I) with respect to the transaction if the transaction involves an investment described in subsection (a)(4)(B)(iii)(III) by a foreign person in a United States business that maintains or collects information about genetic tests of United States citizens, including any such information relating to genomic sequencing. . (b) Consultation with Secretary of Health and Human Services Section 721(k)(6) of the Defense Production Act of 1950 ( 50 U.S.C. 4565(k)(6) ) is amended— (1) by striking The chairperson and inserting the following: (A) In general The chairperson